Regarding the expression of KCC3 in the invasive front of the tumor, we divided ESCC patients into 2 groups, negative (n = 22) and positive (n = 48), and compared their clinicopathological features (Table 2). The gene discussed is SLC12A6; the disease is neoplasm.